About AveXis, Inc.

AveXis is now Novartis Gene Therapies. Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases.

Private
Biotechnology
2010
United States
Bannockburn, Illinois
18475728280
medinfo@avexis.com
NASDAQ
AVXS

Annual Revenue

$10 to $50 million

Employees

201-500

AveXis, Inc. Contacts

We have 1116 contacts in our database, out of which 24% are decision makers. The distribution of leads are as follows:

Classification of AveXis, Inc. Contacts as per Designation Label:
Classification of AveXis, Inc. Contacts by Functional Responsibility (Top 5):

AveXis, Inc. Website Traffic Analysis

In August, 2019 avexis.com's total website visitor was 21932, declined by 16% from previous month. Some key metrics are Average time spent on site is 34 minutes, Bounce Rate is 68% and average page per visit is 1 respectively.

Site Traffic by Month
Traffic Sources
Geographic Breakdown
Average Visitor Per Month Icon
29486
Time Spend Icon
34 Minutes
Bounce Rate Icon
68%
Page Per Visit Icon
1

Frequently Asked Question About AveXis, Inc.

1. AveXis, Inc. was founded in 2010.
2. AveXis, Inc. specialize in Gene Therapy, Synthetic Biology.
3. $10 to $50 million.
4. 201-500 employees.
5. AveXis, Inc. is a Private company.
6. AveXis, Inc. headquarter located in Bannockburn Illinois, United States.
7. We have 1116 contacts in our database.
8. We have 268 decision makers in our database.

Flash News

  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse